(Q42097618)

English

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

scientific article published on July 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 October 2017

0 references

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis (English)

1 reference

Europe PubMed Central

16 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

deep vein thrombosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Leizorovicz A

1

1 reference

Europe PubMed Central

16 October 2017

Simonneau G

2

1 reference

Europe PubMed Central

16 October 2017

Decousus H

3

1 reference

Europe PubMed Central

16 October 2017

Boissel JP

4

1 reference

Europe PubMed Central

16 October 2017

language of work or name

0 references

publication date

1 July 1994

1 reference

Europe PubMed Central

16 October 2017

1 reference

Europe PubMed Central

16 October 2017

309

1 reference

Europe PubMed Central

16 October 2017

299-304

1 reference

Europe PubMed Central

16 October 2017

6950

1 reference

Europe PubMed Central

16 October 2017

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Deep vein thrombosis of the legs: new therapy by means of low molecular weight heparins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Incidence of venous thromboembolism verified by necropsy over 30 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Treatment of deep venous thrombosis by fixed doses of a low-molecular-weight heparin (CY216).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Can meta-analyses be trusted?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Surrogate endpoints: a basis for a rational approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Registry of multicenter clinical trials. Twelfth and thirteenth report--1990-1991. The Council on Thrombosis and Haemostasis of the International Society and Federation of Cardiology. The Scientific and Standardization Committee of the International

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Low molecular weight heparin in prevention of perioperative thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

29 May 2018

Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

17 August 2018

A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

17 August 2018

Epidemiology of chronic venous ulcers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2540865

17 August 2018

Occult malignant neoplasm in patients with deep venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The need for standardization of low molecular weight heparin (LMWH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis and multiple publication of clinical trial reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of statistical methods for combining event rates from clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deep venous thrombosis and pulmonary embolism. Risk of subsequent malignant neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/8086867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.309.6950.299

1 reference

Europe PubMed Central

16 October 2017

1 reference

Europe PubMed Central

16 October 2017

1 reference

Europe PubMed Central

16 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42097618&oldid=1933638341"